VKTX Viking Therapeutics | $28.87
+3.3% | 4/29/2025 | Upgraded by | Cantor Fitzgerald | Analyst S. Seedhouse | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of Viking Therapeutics (NASDAQ:VKTX) on 4/29/2025 |
KRRO Korro Bio | $17.75
+6.5% | 4/29/2025 | Upgraded by | Cantor Fitzgerald | Analyst S. Seedhouse | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of Korro Bio (NASDAQ:KRRO) on 4/29/2025 |
EDIT Editas Medicine | $1.65
+6.5% | 4/29/2025 | Upgraded by | Cantor Fitzgerald | Analyst E. Schmidt | Hold -> Strong-Buy | | High | View details for Cantor Fitzgerald rating of Editas Medicine (NASDAQ:EDIT) on 4/29/2025 |
ATXS Astria Therapeutics | $5.16
+0.8% | 4/29/2025 | Upgraded by | Cantor Fitzgerald | Analyst S. Seedhouse | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Astria Therapeutics (NASDAQ:ATXS) on 4/29/2025 |
APLS Apellis Pharmaceuticals | $19.21
+5.5% | 4/29/2025 | Initiated by | Cantor Fitzgerald | Analyst Eliana Merle | Overweight | $44.00 | Low | View details for Cantor Fitzgerald rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 4/29/2025 |
PHVS Pharvaris | $18.48
+7.0% | 4/29/2025 | Initiated by | Cantor Fitzgerald | Analyst Steven Seedhouse | Overweight | $28.00 | Medium | View details for Cantor Fitzgerald rating of Pharvaris (NASDAQ:PHVS) on 4/29/2025 |
WVE Wave Life Sciences | $7.72
+5.2% | 4/29/2025 | Initiated by | Cantor Fitzgerald | Analyst Steven Seedhouse | Overweight | $10.00 | High | View details for Cantor Fitzgerald rating of Wave Life Sciences (NASDAQ:WVE) on 4/29/2025 |
PRQR ProQR Therapeutics | $1.66
+1.8% | 4/29/2025 | Initiated by | Cantor Fitzgerald | Analyst S. Seedhouse | Overweight | $8.00 | High | View details for Cantor Fitzgerald rating of ProQR Therapeutics (NASDAQ:PRQR) on 4/29/2025 |
BCRX BioCryst Pharmaceuticals | $8.85
+4.9% | 4/29/2025 | Initiated by | Cantor Fitzgerald | Analyst Steven Seedhouse | Overweight | $20.00 | Medium | View details for Cantor Fitzgerald rating of BioCryst Pharmaceuticals (NASDAQ:BCRX) on 4/29/2025 |
IFRX InflaRx | $1.70
+17.2% | 4/29/2025 | Initiated by | Cantor Fitzgerald | Analyst Steven Seedhouse | Overweight | $10.00 | High | View details for Cantor Fitzgerald rating of InflaRx (NASDAQ:IFRX) on 4/29/2025 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. |
ATXS Astria Therapeutics | $5.16
+0.8% | 4/28/2025 | Initiated by | Cantor Fitzgerald | Analyst Steven Seedhouse | Overweight | $47.00 | Low | View details for Cantor Fitzgerald rating of Astria Therapeutics (NASDAQ:ATXS) on 4/28/2025 |
KRRO Korro Bio | $17.75
+6.5% | 4/28/2025 | Initiated by | Cantor Fitzgerald | Analyst Steven Seedhouse | Overweight | $74.00 | High | View details for Cantor Fitzgerald rating of Korro Bio (NASDAQ:KRRO) on 4/28/2025 |
VKTX Viking Therapeutics | $28.87
+3.3% | 4/28/2025 | Initiated by | Cantor Fitzgerald | Analyst Steven Seedhouse | Overweight | $104.00 | High | View details for Cantor Fitzgerald rating of Viking Therapeutics (NASDAQ:VKTX) on 4/28/2025 |
CGON CG Oncology | $26.94
| 4/28/2025 | Reiterated by | Cantor Fitzgerald | Analyst Josh Schimmer | Overweight -> Overweight | $75.00 -> $75.00 | High | View details for Cantor Fitzgerald rating of CG Oncology (NASDAQ:CGON) on 4/28/2025 |
TSHA Taysha Gene Therapies | $1.94
+6.6% | 4/28/2025 | Reiterated by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $7.00 -> $7.00 | Medium | View details for Cantor Fitzgerald rating of Taysha Gene Therapies (NASDAQ:TSHA) on 4/28/2025 |
AMD Advanced Micro Devices | $97.35
+1.3% | 4/28/2025 | Reiterated by | Cantor Fitzgerald | Analyst C J Muse | Overweight -> Overweight | $180.00 | Low | View details for Cantor Fitzgerald rating of Advanced Micro Devices (NASDAQ:AMD) on 4/28/2025 |
UAL United Airlines | $68.82
-0.2% | 4/22/2025 | Target Set by | Cantor Fitzgerald | Analyst Tom Fitzgerald | | $88.00 | Low | View details for Cantor Fitzgerald rating of United Airlines (NASDAQ:UAL) on 4/22/2025 |
GOOG Alphabet | $160.89
-0.7% | 4/25/2025 | Reiterated by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Neutral -> Neutral | $171.00 | High | View details for Cantor Fitzgerald rating of Alphabet (NASDAQ:GOOG) on 4/25/2025 |
LRCX Lam Research | $71.67
+1.1% | 4/24/2025 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $90.00 -> $90.00 | Low | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 4/24/2025 |
FTNT Fortinet | $103.76
-0.4% | 4/24/2025 | Target Lowered by | Cantor Fitzgerald | Analyst J. Ruykhaver | Neutral -> Neutral | $115.00 -> $100.00 | Low | View details for Cantor Fitzgerald rating of Fortinet (NASDAQ:FTNT) on 4/24/2025 |
CYBR CyberArk Software | $352.16
-0.1% | 4/24/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $400.00 -> $400.00 | Low | View details for Cantor Fitzgerald rating of CyberArk Software (NASDAQ:CYBR) on 4/24/2025 |
NOW ServiceNow | $955.02
+1.3% | 4/24/2025 | Reiterated by | Cantor Fitzgerald | Analyst T. Blakey | Overweight -> Overweight | $1,048.00 -> $1,048.00 | Low | View details for Cantor Fitzgerald rating of ServiceNow (NYSE:NOW) on 4/24/2025 |
PI Impinj | $92.13
+2.7% | 4/24/2025 | Reiterated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight -> Overweight | $133.00 -> $133.00 | High | View details for Cantor Fitzgerald rating of Impinj (NASDAQ:PI) on 4/24/2025 |
TXN Texas Instruments | $160.05
+0.4% | 4/24/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Matthew Prisco | Neutral -> Neutral | $200.00 -> $170.00 | Low | View details for Cantor Fitzgerald rating of Texas Instruments (NASDAQ:TXN) on 4/24/2025 |
TSLA Tesla | $282.16
-3.4% | 4/23/2025 | Target Lowered by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Overweight | $425.00 -> $355.00 | High | View details for Cantor Fitzgerald rating of Tesla (NASDAQ:TSLA) on 4/23/2025 |
TVTX Travere Therapeutics | $20.81
+3.6% | 4/23/2025 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Travere Therapeutics (NASDAQ:TVTX) on 4/23/2025 |
SMMT Summit Therapeutics | $24.12
+2.1% | 4/23/2025 | Reiterated by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Summit Therapeutics (NASDAQ:SMMT) on 4/23/2025 |
ELV Elevance Health | $420.82
+1.7% | 4/23/2025 | Reiterated by | Cantor Fitzgerald | Analyst Sarah James | Overweight -> Overweight | $485.00 -> $485.00 | Low | View details for Cantor Fitzgerald rating of Elevance Health (NYSE:ELV) on 4/23/2025 |
CRM Salesforce | $268.46
+0.3% | 4/23/2025 | Initiated by | Cantor Fitzgerald | Analyst Carter Gould | Overweight | $210.00 | Medium | View details for Cantor Fitzgerald rating of Salesforce (NYSE:CRM) on 4/23/2025 |
SMRT SmartRent | $0.96
+5.0% | 4/22/2025 | Upgraded by | Cantor Fitzgerald | Analyst Y. Lee | Hold | | High | View details for Cantor Fitzgerald rating of SmartRent (NYSE:SMRT) on 4/22/2025 |
ABBV AbbVie | $195.15
+0.8% | 4/22/2025 | Initiated by | Cantor Fitzgerald | Analyst Carter Gould | Overweight | $210.00 | Medium | View details for Cantor Fitzgerald rating of AbbVie (NYSE:ABBV) on 4/22/2025 |
BMY Bristol-Myers Squibb | $50.21
+2.0% | 4/22/2025 | Reiterated by | Cantor Fitzgerald | Analyst Carter Gould | Neutral -> Neutral | $55.00 -> $55.00 | Medium | View details for Cantor Fitzgerald rating of Bristol-Myers Squibb (NYSE:BMY) on 4/22/2025 |
MRK Merck & Co., Inc. | $85.23
+0.6% | 4/22/2025 | Initiated by | Cantor Fitzgerald | Analyst Carter Gould | Neutral | $85.00 | Low | View details for Cantor Fitzgerald rating of Merck & Co., Inc. (NYSE:MRK) on 4/22/2025 |
PCVX Vaxcyte | $35.84
+3.1% | 4/22/2025 | Initiated by | Cantor Fitzgerald | Analyst Carter Gould | Overweight | | High | View details for Cantor Fitzgerald rating of Vaxcyte (NASDAQ:PCVX) on 4/22/2025 |
PFE Pfizer | $24.41
+2.6% | 4/22/2025 | Initiated by | Cantor Fitzgerald | Analyst Carter Gould | Overweight -> Neutral | $24.00 | Medium | View details for Cantor Fitzgerald rating of Pfizer (NYSE:PFE) on 4/22/2025 |
VRTX Vertex Pharmaceuticals | $509.50
+1.2% | 4/22/2025 | Reiterated by | Cantor Fitzgerald | Analyst Carter Gould | Overweight | $535.00 | Medium | View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 4/22/2025 |
LLY Eli Lilly and Company | $899.78
+1.6% | 4/22/2025 | Initiated by | Cantor Fitzgerald | Analyst Carter Gould | Overweight | $975.00 | Low | View details for Cantor Fitzgerald rating of Eli Lilly and Company (NYSE:LLY) on 4/22/2025 |
AMGN Amgen | $290.92
+0.8% | 4/22/2025 | Initiated by | Cantor Fitzgerald | Analyst C. Gould | Overweight -> Neutral | $305.00 | Medium | View details for Cantor Fitzgerald rating of Amgen (NASDAQ:AMGN) on 4/22/2025 |
GILD Gilead Sciences | $106.54
+2.2% | 4/22/2025 | Initiated by | Cantor Fitzgerald | Analyst Carter Gould | Overweight | $125.00 | Medium | View details for Cantor Fitzgerald rating of Gilead Sciences (NASDAQ:GILD) on 4/22/2025 |
REGN Regeneron Pharmaceuticals | $598.76
+5.2% | 4/22/2025 | Initiated by | Cantor Fitzgerald | Analyst Carter Gould | Overweight | $695.00 | High | View details for Cantor Fitzgerald rating of Regeneron Pharmaceuticals (NASDAQ:REGN) on 4/22/2025 |
Elon Reveals Why There Soon Won’t Be Any Money For Social Security (Ad) Elon Musk's Near-Death Experience Sparks Dire Warning for Americans
After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late. See why thousands of forward-thinking retirement savers are now requesting this FREE 2025 Wealth Pro |
INTC Intel | $20.10
-1.2% | 4/21/2025 | Target Lowered by | Cantor Fitzgerald | - | Neutral | $29.00 -> $20.00 | High | View details for Cantor Fitzgerald rating of Intel (NASDAQ:INTC) on 4/21/2025 |
VRNA Verona Pharma | $72.07
-1.6% | 4/21/2025 | Initiated by | Cantor Fitzgerald | Analyst O. Brayer | Overweight | $80.00 | Low | View details for Cantor Fitzgerald rating of Verona Pharma (NASDAQ:VRNA) on 4/21/2025 |
ABNB Airbnb | $121.92
-2.8% | 4/16/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Underweight -> Underweight | $130.00 -> $101.00 | Low | View details for Cantor Fitzgerald rating of Airbnb (NASDAQ:ABNB) on 4/16/2025 |
BKNG Booking | $5,099.28
+3.9% | 4/16/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Neutral -> Neutral | $5,540.00 -> $4,330.00 | Low | View details for Cantor Fitzgerald rating of Booking (NASDAQ:BKNG) on 4/16/2025 |
DASH DoorDash | $192.89
+0.9% | 4/16/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Overweight -> Overweight | $230.00 -> $210.00 | Low | View details for Cantor Fitzgerald rating of DoorDash (NASDAQ:DASH) on 4/16/2025 |
GOOGL Alphabet | $158.80
-0.8% | 4/16/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Neutral -> Neutral | $200.00 -> $159.00 | Low | View details for Cantor Fitzgerald rating of Alphabet (NASDAQ:GOOGL) on 4/16/2025 |
MELI MercadoLibre | $2,330.85
+2.2% | 4/16/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Overweight -> Overweight | $3,000.00 -> $2,400.00 | Low | View details for Cantor Fitzgerald rating of MercadoLibre (NASDAQ:MELI) on 4/16/2025 |
META Meta Platforms | $549.00
-1.0% | 4/16/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Overweight -> Overweight | $790.00 -> $624.00 | Low | View details for Cantor Fitzgerald rating of Meta Platforms (NASDAQ:META) on 4/16/2025 |
SHOP Shopify | $95.00
-4.0% | 4/16/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Neutral -> Neutral | $120.00 -> $80.00 | Low | View details for Cantor Fitzgerald rating of Shopify (NYSE:SHOP) on 4/16/2025 |
SPOT Spotify Technology | $614.81
+6.6% | 4/16/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Neutral -> Neutral | $600.00 -> $520.00 | Low | View details for Cantor Fitzgerald rating of Spotify Technology (NYSE:SPOT) on 4/16/2025 |
UBER Uber Technologies | $81.07
+2.1% | 4/16/2025 | Reiterated by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Overweight -> Overweight | $80.00 -> $80.00 | Low | View details for Cantor Fitzgerald rating of Uber Technologies (NYSE:UBER) on 4/16/2025 |
NVDA NVIDIA | $108.92
-0.1% | 4/16/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $200.00 -> $200.00 | Low | View details for Cantor Fitzgerald rating of NVIDIA (NASDAQ:NVDA) on 4/16/2025 |
NOW ServiceNow | $955.02
+1.3% | 4/16/2025 | Reiterated by | Cantor Fitzgerald | Analyst T. Blakey | Overweight -> Overweight | $1,048.00 -> $1,048.00 | High | View details for Cantor Fitzgerald rating of ServiceNow (NYSE:NOW) on 4/16/2025 |
AMZN Amazon.com | $184.42
-1.6% | 4/16/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Overweight -> Overweight | $270.00 -> $230.00 | Low | View details for Cantor Fitzgerald rating of Amazon.com (NASDAQ:AMZN) on 4/16/2025 |
APLD Applied Digital | $4.54
+1.3% | 4/15/2025 | Target Lowered by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $14.00 -> $7.00 | High | View details for Cantor Fitzgerald rating of Applied Digital (NASDAQ:APLD) on 4/15/2025 |
VERV Verve Therapeutics | $5.67
+3.8% | 4/15/2025 | Upgraded by | Cantor Fitzgerald | Analyst Rick Bienkowski | Neutral -> Overweight | | High | View details for Cantor Fitzgerald rating of Verve Therapeutics (NASDAQ:VERV) on 4/15/2025 |
DNLI Denali Therapeutics | $16.65
+0.9% | 4/10/2025 | Upgraded by | Cantor Fitzgerald | Analyst J. Schimmer | Neutral -> Overweight | | High | View details for Cantor Fitzgerald rating of Denali Therapeutics (NASDAQ:DNLI) on 4/10/2025 |
COIN Coinbase Global | $202.89
-1.6% | 4/8/2025 | Initiated by | Cantor Fitzgerald | Analyst Brett Knoblauch | Overweight | $245.00 | High | View details for Cantor Fitzgerald rating of Coinbase Global (NASDAQ:COIN) on 4/8/2025 |
FIVN Five9 | $25.14
-0.8% | 4/2/2025 | Reiterated by | Cantor Fitzgerald | Analyst T. Blakey | Overweight -> Overweight | | Medium | View details for Cantor Fitzgerald rating of Five9 (NASDAQ:FIVN) on 4/2/2025 |
SNOW Snowflake | $159.49
-0.5% | 4/2/2025 | Reiterated by | Cantor Fitzgerald | Analyst T. Blakey | Overweight -> Overweight | $183.00 | High | View details for Cantor Fitzgerald rating of Snowflake (NYSE:SNOW) on 4/2/2025 |
TVTX Travere Therapeutics | $20.81
+3.6% | 4/3/2025 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Travere Therapeutics (NASDAQ:TVTX) on 4/3/2025 |
LCID Lucid Group | $2.51
-2.0% | 4/3/2025 | Reiterated by | Cantor Fitzgerald | Analyst Andres Sheppard | Neutral -> Neutral | $3.00 -> $3.00 | Medium | View details for Cantor Fitzgerald rating of Lucid Group (NASDAQ:LCID) on 4/3/2025 |
TSLA Tesla | $282.16
-3.4% | 4/3/2025 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Overweight | $425.00 -> $425.00 | Medium | View details for Cantor Fitzgerald rating of Tesla (NASDAQ:TSLA) on 4/3/2025 |
ZS Zscaler | $226.17
+1.0% | 4/3/2025 | Upgraded by | Cantor Fitzgerald | Analyst J. Ruykhaver | Neutral -> Overweight | $220.00 -> $250.00 | High | View details for Cantor Fitzgerald rating of Zscaler (NASDAQ:ZS) on 4/3/2025 |
MESO Mesoblast | $11.40
-4.3% | 3/31/2025 | Upgraded by | Cantor Fitzgerald | Analyst O. Brayer | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of Mesoblast (NASDAQ:MESO) on 3/31/2025 |
META Meta Platforms | $549.00
-1.0% | 4/2/2025 | Reiterated by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Overweight -> Overweight | $790.00 -> $790.00 | Low | View details for Cantor Fitzgerald rating of Meta Platforms (NASDAQ:META) on 4/2/2025 |
ITCI Intra-Cellular Therapies | $131.87
| 4/2/2025 | Reiterated by | Cantor Fitzgerald | Analyst C. Duncan | Neutral -> Neutral | $132.00 -> $132.00 | Low | View details for Cantor Fitzgerald rating of Intra-Cellular Therapies (NASDAQ:ITCI) on 4/2/2025 |
TEAM Atlassian | $228.31
-0.1% | 4/2/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Neutral -> Overweight | $304.00 -> $272.00 | High | View details for Cantor Fitzgerald rating of Atlassian (NASDAQ:TEAM) on 4/2/2025 |
AARD Aardvark Therapeutics | $11.11
-2.8% | 4/1/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight -> Overweight | $50.00 -> $50.00 | High | View details for Cantor Fitzgerald rating of Aardvark Therapeutics (NASDAQ:AARD) on 4/1/2025 |
IMTX Immatics | $5.00
+2.7% | 4/1/2025 | Reiterated by | Cantor Fitzgerald | Analyst Eric Schmidt | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Immatics (NASDAQ:IMTX) on 4/1/2025 |
NNOX Nano-X Imaging | $5.03
+0.8% | 4/1/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $12.00 -> $9.00 | High | View details for Cantor Fitzgerald rating of Nano-X Imaging (NASDAQ:NNOX) on 4/1/2025 |
TENB Tenable | $30.57
-9.2% | 3/31/2025 | Initiated by | Cantor Fitzgerald | Analyst Jonathan Ruykhaver | Overweight | $50.00 | High | View details for Cantor Fitzgerald rating of Tenable (NASDAQ:TENB) on 3/31/2025 |
OKTA Okta | $112.16
-0.3% | 3/31/2025 | Initiated by | Cantor Fitzgerald | Analyst Jonathan Ruykhaver | Overweight | $130.00 | Medium | View details for Cantor Fitzgerald rating of Okta (NASDAQ:OKTA) on 3/31/2025 |
DDD 3D Systems | $1.83
-3.7% | 3/28/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Troy Jensen | Overweight -> Overweight | $5.75 -> $5.00 | Medium | View details for Cantor Fitzgerald rating of 3D Systems (NYSE:DDD) on 3/28/2025 |
LCID Lucid Group | $2.51
-2.0% | 3/28/2025 | Reiterated by | Cantor Fitzgerald | Analyst Andres Sheppard | Neutral -> Neutral | $3.00 -> $3.00 | Low | View details for Cantor Fitzgerald rating of Lucid Group (NASDAQ:LCID) on 3/28/2025 |
CMPS COMPASS Pathways | $3.98
+5.6% | 3/28/2025 | Reiterated by | Cantor Fitzgerald | Analyst Charles Duncan | Overweight -> Overweight | | Medium | View details for Cantor Fitzgerald rating of COMPASS Pathways (NASDAQ:CMPS) on 3/28/2025 |
ZLAB Zai Lab | $31.69
-0.5% | 3/27/2025 | Reiterated by | Cantor Fitzgerald | Analyst L. Watsek | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Zai Lab (NASDAQ:ZLAB) on 3/27/2025 |
SLNO Soleno Therapeutics | $74.86
-0.5% | 3/27/2025 | Target Raised by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $67.00 -> $123.00 | High | View details for Cantor Fitzgerald rating of Soleno Therapeutics (NASDAQ:SLNO) on 3/27/2025 |
ACRV Acrivon Therapeutics | $1.40
-2.8% | 3/26/2025 | Reiterated by | Cantor Fitzgerald | Analyst L. Watsek | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Acrivon Therapeutics (NASDAQ:ACRV) on 3/26/2025 |
XFOR X4 Pharmaceuticals | $4.31
-0.9% | 3/26/2025 | Reiterated by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $90.00 -> $90.00 | Low | View details for Cantor Fitzgerald rating of X4 Pharmaceuticals (NASDAQ:XFOR) on 3/26/2025 |
LUCD Lucid Diagnostics | $1.25
-0.8% | 3/26/2025 | Reiterated by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $2.00 -> $2.00 | Low | View details for Cantor Fitzgerald rating of Lucid Diagnostics (NASDAQ:LUCD) on 3/26/2025 |
SMTI Sanara MedTech | $31.94
-0.6% | 3/26/2025 | Reiterated by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $46.00 -> $46.00 | Medium | View details for Cantor Fitzgerald rating of Sanara MedTech (NASDAQ:SMTI) on 3/26/2025 |
ARTV Artiva Biotherapeutics | $2.39
-2.4% | 3/25/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Josh Schimmer | Overweight -> Overweight | $23.00 -> $20.00 | Medium | View details for Cantor Fitzgerald rating of Artiva Biotherapeutics (NASDAQ:ARTV) on 3/25/2025 |
LUNR Intuitive Machines | $8.20
-4.7% | 3/25/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Andres Sheppard | Overweight -> Overweight | $15.00 -> $13.00 | Medium | View details for Cantor Fitzgerald rating of Intuitive Machines (NASDAQ:LUNR) on 3/25/2025 |
OUST Ouster | $7.43
-3.8% | 3/21/2025 | Target Raised by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Overweight | $10.00 -> $11.00 | High | View details for Cantor Fitzgerald rating of Ouster (NYSE:OUST) on 3/21/2025 |
MU Micron Technology | $76.95
+0.1% | 3/21/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $130.00 -> $130.00 | High | View details for Cantor Fitzgerald rating of Micron Technology (NASDAQ:MU) on 3/21/2025 |
PL Planet Labs PBC | $3.29
-4.1% | 3/21/2025 | Reiterated by | Cantor Fitzgerald | Analyst C. Canfield | Overweight -> Overweight | $6.30 -> $6.30 | High | View details for Cantor Fitzgerald rating of Planet Labs PBC (NYSE:PL) on 3/21/2025 |
SMMT Summit Therapeutics | $24.12
+2.1% | 3/21/2025 | Initiated by | Cantor Fitzgerald | Analyst Eric Schmidt | Overweight | | Low | View details for Cantor Fitzgerald rating of Summit Therapeutics (NASDAQ:SMMT) on 3/21/2025 |
GLYC GlycoMimetics | $0.25
+6.5% | 3/21/2025 | Initiated by | Cantor Fitzgerald | Analyst Eric Schmidt | Overweight | | Low | View details for Cantor Fitzgerald rating of GlycoMimetics (NASDAQ:GLYC) on 3/21/2025 |
ALMS Alumis | $4.14
-4.4% | 3/20/2025 | Reiterated by | Cantor Fitzgerald | Analyst Eric Schmidt | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Alumis (NASDAQ:ALMS) on 3/20/2025 |
Elon Reveals Why There Soon Won’t Be Any Money For Social Security (Ad) Elon Musk's Near-Death Experience Sparks Dire Warning for Americans
After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late. See why thousands of forward-thinking retirement savers are now requesting this FREE 2025 Wealth Pro |
DOMO Domo | $7.43
-1.8% | 3/20/2025 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $11.00 -> $11.00 | Medium | View details for Cantor Fitzgerald rating of Domo (NASDAQ:DOMO) on 3/20/2025 |
CI The Cigna Group | $340.21
+0.9% | 3/20/2025 | Target Raised by | Cantor Fitzgerald | Analyst Sarah James | Overweight -> Overweight | $350.00 -> $365.00 | Low | View details for Cantor Fitzgerald rating of The Cigna Group (NYSE:CI) on 3/20/2025 |
CAPR Capricor Therapeutics | $12.70
+1.1% | 3/20/2025 | Reiterated by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $30.00 -> $30.00 | High | View details for Cantor Fitzgerald rating of Capricor Therapeutics (NASDAQ:CAPR) on 3/20/2025 |
TWI Titan International | $7.32
-0.1% | 3/20/2025 | Initiated by | Cantor Fitzgerald | Analyst Derek Soderberg | Overweight | $11.00 | High | View details for Cantor Fitzgerald rating of Titan International (NYSE:TWI) on 3/20/2025 |
GOOG Alphabet | $160.89
-0.7% | 3/19/2025 | Reiterated by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Neutral -> Neutral | $200.00 | Medium | View details for Cantor Fitzgerald rating of Alphabet (NASDAQ:GOOG) on 3/19/2025 |
NVDA NVIDIA | $108.92
-0.1% | 3/19/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $200.00 -> $200.00 | Low | View details for Cantor Fitzgerald rating of NVIDIA (NASDAQ:NVDA) on 3/19/2025 |
GOOGL Alphabet | $158.80
-0.8% | 3/19/2025 | Reiterated by | Cantor Fitzgerald | Analyst Deepak Mathivanan | Neutral -> Neutral | $200.00 -> $200.00 | Medium | View details for Cantor Fitzgerald rating of Alphabet (NASDAQ:GOOGL) on 3/19/2025 |
TSLA Tesla | $282.16
-3.4% | 3/19/2025 | Upgraded by | Cantor Fitzgerald | Analyst Andres Sheppard | Neutral -> Overweight | $425.00 -> $425.00 | Medium | View details for Cantor Fitzgerald rating of Tesla (NASDAQ:TSLA) on 3/19/2025 |
IRON Disc Medicine | $49.42
+4.8% | 3/18/2025 | Target Raised by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $99.00 -> $132.00 | Medium | View details for Cantor Fitzgerald rating of Disc Medicine (NASDAQ:IRON) on 3/18/2025 |
BLTE Belite Bio | $61.48
-1.3% | 3/18/2025 | Reiterated by | Cantor Fitzgerald | Analyst Jennifer Kim | Overweight -> Overweight | | Low | View details for Cantor Fitzgerald rating of Belite Bio (NASDAQ:BLTE) on 3/18/2025 |
MREO Mereo BioPharma Group | $2.59
+2.8% | 3/18/2025 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight -> Overweight | $7.00 -> $7.00 | High | View details for Cantor Fitzgerald rating of Mereo BioPharma Group (NASDAQ:MREO) on 3/18/2025 |
SRPT Sarepta Therapeutics | $62.40
+2.5% | 3/18/2025 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight -> Overweight | $163.00 -> $163.00 | High | View details for Cantor Fitzgerald rating of Sarepta Therapeutics (NASDAQ:SRPT) on 3/18/2025 |
ACRS Aclaris Therapeutics | $1.38
+3.8% | 3/18/2025 | Initiated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight -> Overweight | | Low | View details for Cantor Fitzgerald rating of Aclaris Therapeutics (NASDAQ:ACRS) on 3/18/2025 |
RBRK Rubrik | $70.60
-0.2% | 3/14/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $85.00 -> $85.00 | High | View details for Cantor Fitzgerald rating of Rubrik (NYSE:RBRK) on 3/14/2025 |
EVEX EVE | $3.53
-6.6% | 3/14/2025 | Reiterated by | Cantor Fitzgerald | Analyst Andres Sheppard | Overweight -> Overweight | $5.00 -> $5.00 | High | View details for Cantor Fitzgerald rating of EVE (NYSE:EVEX) on 3/14/2025 |
NVMI Nova | $196.21
+0.8% | 3/14/2025 | Target Lowered by | Cantor Fitzgerald | Analyst M. Prisco | Overweight -> Overweight | $315.00 -> $300.00 | Low | View details for Cantor Fitzgerald rating of Nova (NASDAQ:NVMI) on 3/14/2025 |
TARA Protara Therapeutics | $3.50
+2.9% | 3/14/2025 | Initiated by | Cantor Fitzgerald | Analyst Li Watsek | Overweight | | Low | View details for Cantor Fitzgerald rating of Protara Therapeutics (NASDAQ:TARA) on 3/14/2025 |
BCAX Bicara Therapeutics | $14.37
-3.4% | 3/13/2025 | Reiterated by | Cantor Fitzgerald | Analyst E. Schmidt | Overweight -> Overweight | $13.01 -> $13.01 | Medium | View details for Cantor Fitzgerald rating of Bicara Therapeutics (NASDAQ:BCAX) on 3/13/2025 |
S SentinelOne | $18.50
-1.5% | 3/13/2025 | Target Lowered by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $30.00 -> $24.00 | High | View details for Cantor Fitzgerald rating of SentinelOne (NYSE:S) on 3/13/2025 |
ZVRA Zevra Therapeutics | $7.33
+1.4% | 3/12/2025 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight -> Overweight | $25.00 -> $25.00 | High | View details for Cantor Fitzgerald rating of Zevra Therapeutics (NASDAQ:ZVRA) on 3/12/2025 |
TER Teradyne | $74.21
-0.9% | 3/12/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $150.00 -> $110.00 | Low | View details for Cantor Fitzgerald rating of Teradyne (NASDAQ:TER) on 3/12/2025 |
BEAM Beam Therapeutics | $19.93
+1.1% | 3/12/2025 | Reiterated by | Cantor Fitzgerald | Analyst R. Bienkowski | Overweight -> Overweight | | Medium | View details for Cantor Fitzgerald rating of Beam Therapeutics (NASDAQ:BEAM) on 3/12/2025 |
VYGR Voyager Therapeutics | $3.56
-0.8% | 3/12/2025 | Reiterated by | Cantor Fitzgerald | Analyst P. Stavropoulos | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Voyager Therapeutics (NASDAQ:VYGR) on 3/12/2025 |
ORCL Oracle | $140.77
0.0% | 3/11/2025 | Target Lowered by | Cantor Fitzgerald | Analyst T. Blakey | Overweight -> Overweight | $214.00 -> $175.00 | High | View details for Cantor Fitzgerald rating of Oracle (NYSE:ORCL) on 3/11/2025 |
NOW ServiceNow | $955.02
+1.3% | 3/11/2025 | Reiterated by | Cantor Fitzgerald | Analyst T. Blakey | Overweight -> Overweight | $1,048.00 -> $1,048.00 | Low | View details for Cantor Fitzgerald rating of ServiceNow (NYSE:NOW) on 3/11/2025 |
LFMD LifeMD | $7.36
-14.6% | 3/11/2025 | Reiterated by | Cantor Fitzgerald | Analyst Sarah James | Overweight -> Overweight | $15.00 -> $15.00 | High | View details for Cantor Fitzgerald rating of LifeMD (NASDAQ:LFMD) on 3/11/2025 |
TBRG TruBridge | $26.03
-0.1% | 3/11/2025 | Target Raised by | Cantor Fitzgerald | Analyst Sarah James | Overweight -> Overweight | $20.00 -> $29.00 | High | View details for Cantor Fitzgerald rating of TruBridge (NASDAQ:TBRG) on 3/11/2025 |
RDW Redwire | $10.77
-4.1% | 3/11/2025 | Reiterated by | Cantor Fitzgerald | Analyst C. Canfield | Overweight -> Overweight | $28.00 -> $28.00 | Medium | View details for Cantor Fitzgerald rating of Redwire (NYSE:RDW) on 3/11/2025 |
HIVE HIVE Digital Technologies | $1.69
-1.7% | 3/11/2025 | Target Lowered by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $10.00 -> $8.00 | Medium | View details for Cantor Fitzgerald rating of HIVE Digital Technologies (NASDAQ:HIVE) on 3/11/2025 |
AARD Aardvark Therapeutics | $11.11
-2.8% | 3/10/2025 | Initiated by | Cantor Fitzgerald | Analyst Josh Schimmer | Overweight | $50.00 | High | View details for Cantor Fitzgerald rating of Aardvark Therapeutics (NASDAQ:AARD) on 3/10/2025 |
WDC Western Digital | $43.86
+8.0% | 3/7/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $95.00 -> $65.00 | Low | View details for Cantor Fitzgerald rating of Western Digital (NASDAQ:WDC) on 3/7/2025 |
ADCT ADC Therapeutics | $1.42
| 3/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst Eric Schmidt | Overweight -> Overweight | | Low | View details for Cantor Fitzgerald rating of ADC Therapeutics (NYSE:ADCT) on 3/7/2025 |
ARCT Arcturus Therapeutics | $12.81
-0.1% | 3/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst Pete Stavropoulos | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Arcturus Therapeutics (NASDAQ:ARCT) on 3/7/2025 |
AVGO Broadcom | $192.47
+0.7% | 3/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $300.00 -> $300.00 | High | View details for Cantor Fitzgerald rating of Broadcom (NASDAQ:AVGO) on 3/7/2025 |
ELUT Elutia | $2.31
+3.1% | 3/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $8.00 -> $8.00 | High | View details for Cantor Fitzgerald rating of Elutia (NASDAQ:ELUT) on 3/7/2025 |
DOMO Domo | $7.43
-1.8% | 3/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst Y. Lee | Overweight -> Overweight | $11.00 -> $11.00 | High | View details for Cantor Fitzgerald rating of Domo (NASDAQ:DOMO) on 3/7/2025 |
BBAI BigBear.ai | $3.40
-5.0% | 3/7/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Jonathan Ruykhaver | Overweight -> Overweight | $8.00 -> $6.00 | Medium | View details for Cantor Fitzgerald rating of BigBear.ai (NYSE:BBAI) on 3/7/2025 |
HUT Hut 8 | $12.31
-5.7% | 3/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $30.00 -> $30.00 | High | View details for Cantor Fitzgerald rating of Hut 8 (NASDAQ:HUT) on 3/7/2025 |
HOOD Robinhood Markets | $49.11
-0.5% | 3/6/2025 | Initiated by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight | $69.00 | High | View details for Cantor Fitzgerald rating of Robinhood Markets (NASDAQ:HOOD) on 3/6/2025 |
NPCE NeuroPace | $11.69
-2.4% | 3/5/2025 | Target Raised by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $19.00 -> $20.00 | High | View details for Cantor Fitzgerald rating of NeuroPace (NASDAQ:NPCE) on 3/5/2025 |
AXGN AxoGen | $16.27
-1.5% | 3/5/2025 | Reiterated by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $24.00 -> $24.00 | Low | View details for Cantor Fitzgerald rating of AxoGen (NASDAQ:AXGN) on 3/5/2025 |
EVGO EVgo | $2.76
-2.5% | 3/5/2025 | Reiterated by | Cantor Fitzgerald | Analyst Andres Sheppard | Overweight -> Overweight | $8.00 -> $8.00 | High | View details for Cantor Fitzgerald rating of EVgo (NASDAQ:EVGO) on 3/5/2025 |
CRWD CrowdStrike | $428.87
-0.5% | 3/5/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $440.00 -> $440.00 | High | View details for Cantor Fitzgerald rating of CrowdStrike (NASDAQ:CRWD) on 3/5/2025 |
ZLAB Zai Lab | $31.69
-0.5% | 3/4/2025 | Upgraded by | Cantor Fitzgerald | Analyst L. Watsek | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Zai Lab (NASDAQ:ZLAB) on 3/4/2025 |
MDB MongoDB | $172.17
-1.4% | 3/5/2025 | Initiated by | Cantor Fitzgerald | Analyst T. Blakey | Overweight | $344.00 | High | View details for Cantor Fitzgerald rating of MongoDB (NASDAQ:MDB) on 3/5/2025 |
GAMB Gambling.com Group | $12.87
-0.1% | 3/5/2025 | Initiated by | Cantor Fitzgerald | Analyst E. James | Overweight | $20.00 | High | View details for Cantor Fitzgerald rating of Gambling.com Group (NASDAQ:GAMB) on 3/5/2025 |
ROIV Roivant Sciences | $11.62
+2.9% | 3/4/2025 | Upgraded by | Cantor Fitzgerald | Analyst P. Agrawal | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Roivant Sciences (NASDAQ:ROIV) on 3/4/2025 |
MESO Mesoblast | $11.40
-4.3% | 3/4/2025 | Upgraded by | Cantor Fitzgerald | Analyst K. Kluska | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of Mesoblast (NASDAQ:MESO) on 3/4/2025 |
KURA Kura Oncology | $6.56
+0.6% | 3/4/2025 | Upgraded by | Cantor Fitzgerald | Analyst L. Watsek | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of Kura Oncology (NASDAQ:KURA) on 3/4/2025 |
IMVT Immunovant | $16.15
+6.1% | 3/4/2025 | Upgraded by | Cantor Fitzgerald | Analyst P. Agrawal | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of Immunovant (NASDAQ:IMVT) on 3/4/2025 |
M.A.G.A. is Finished – This Could be even Better (Ad) You’ve no doubt heard Trump’s rally cry: Make America Great Again.
But recently the President made a big change.
Make America Wealthy Again (M.A.W.A). When you see what could happen – I think you’ll be excited. |
CATX Perspective Therapeutics | $2.45
+1.7% | 3/4/2025 | Upgraded by | Cantor Fitzgerald | Analyst L. Watsek | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Perspective Therapeutics (NYSE:CATX) on 3/4/2025 |
ARDX Ardelyx | $5.51
+1.1% | 3/4/2025 | Upgraded by | Cantor Fitzgerald | Analyst P. Agrawal | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Ardelyx (NASDAQ:ARDX) on 3/4/2025 |
ACRS Aclaris Therapeutics | $1.38
+3.8% | 3/4/2025 | Upgraded by | Cantor Fitzgerald | Analyst P. Agrawal | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Aclaris Therapeutics (NASDAQ:ACRS) on 3/4/2025 |
ASTS AST SpaceMobile | $23.21
-2.9% | 3/4/2025 | Reiterated by | Cantor Fitzgerald | Analyst C. Canfield | Overweight -> Overweight | $30.00 -> $30.00 | High | View details for Cantor Fitzgerald rating of AST SpaceMobile (NASDAQ:ASTS) on 3/4/2025 |
SSYS Stratasys | $9.44
-2.0% | 3/4/2025 | Target Raised by | Cantor Fitzgerald | Analyst Troy Jensen | Overweight -> Overweight | $12.00 -> $15.00 | High | View details for Cantor Fitzgerald rating of Stratasys (NASDAQ:SSYS) on 3/4/2025 |
ADMA ADMA Biologics | $23.80
-1.3% | 3/4/2025 | Reiterated by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $25.00 -> $25.00 | High | View details for Cantor Fitzgerald rating of ADMA Biologics (NASDAQ:ADMA) on 3/4/2025 |
GTLB GitLab | $46.67
-1.0% | 3/4/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $80.00 -> $80.00 | High | View details for Cantor Fitzgerald rating of GitLab (NASDAQ:GTLB) on 3/4/2025 |
PLRX Pliant Therapeutics | $1.59
+7.4% | 3/4/2025 | Reiterated by | Cantor Fitzgerald | Analyst Pete Stavropoulos | Neutral | | High | View details for Cantor Fitzgerald rating of Pliant Therapeutics (NASDAQ:PLRX) on 3/4/2025 |
PI Impinj | $92.13
+2.7% | 2/27/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Jensen | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Impinj (NASDAQ:PI) on 2/27/2025 |
KRNT Kornit Digital | $18.88
+1.4% | 2/27/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Jensen | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Kornit Digital (NASDAQ:KRNT) on 2/27/2025 |
CORZ Core Scientific | $8.10
-2.3% | 2/27/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Brett Knoblauch | Overweight -> Overweight | $24.00 -> $21.00 | Low | View details for Cantor Fitzgerald rating of Core Scientific (NASDAQ:CORZ) on 2/27/2025 |
MDXG MiMedx Group | $6.88
-0.6% | 2/27/2025 | Reiterated by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $13.00 -> $13.00 | High | View details for Cantor Fitzgerald rating of MiMedx Group (NASDAQ:MDXG) on 2/27/2025 |
JOBY Joby Aviation | $6.31
-3.8% | 2/27/2025 | Reiterated by | Cantor Fitzgerald | Analyst Andres Sheppard | Overweight -> Overweight | $9.00 -> $9.00 | High | View details for Cantor Fitzgerald rating of Joby Aviation (NYSE:JOBY) on 2/27/2025 |
ACAD ACADIA Pharmaceuticals | $14.60
+1.2% | 2/27/2025 | Reiterated by | Cantor Fitzgerald | Analyst Charles Duncan | Overweight -> Overweight | $28.00 -> $28.00 | High | View details for Cantor Fitzgerald rating of ACADIA Pharmaceuticals (NASDAQ:ACAD) on 2/27/2025 |
EBAY eBay | $68.16
+1.4% | 2/27/2025 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $65.00 -> $70.00 | Medium | View details for Cantor Fitzgerald rating of eBay (NASDAQ:EBAY) on 2/27/2025 |
SNOW Snowflake | $159.49
-0.5% | 2/27/2025 | Target Raised by | Cantor Fitzgerald | Analyst T. Blakey | Overweight -> Overweight | $201.00 -> $228.00 | High | View details for Cantor Fitzgerald rating of Snowflake (NYSE:SNOW) on 2/27/2025 |
NVDA NVIDIA | $108.92
-0.1% | 2/27/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $200.00 -> $200.00 | N/A | View details for Cantor Fitzgerald rating of NVIDIA (NASDAQ:NVDA) on 2/27/2025 |
JAZZ Jazz Pharmaceuticals | $116.96
+0.5% | 2/26/2025 | Downgraded by | Cantor Fitzgerald | Analyst Charles Duncan | Overweight -> Neutral | $140.00 -> $150.00 | Low | View details for Cantor Fitzgerald rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 2/26/2025 |
XMTR Xometry | $25.64
-1.2% | 2/26/2025 | Target Raised by | Cantor Fitzgerald | Analyst Troy Jensen | Underweight -> Underweight | $12.00 -> $20.00 | High | View details for Cantor Fitzgerald rating of Xometry (NASDAQ:XMTR) on 2/26/2025 |
DOCN DigitalOcean | $30.92
-1.6% | 2/26/2025 | Target Raised by | Cantor Fitzgerald | Analyst T. Blakey | Neutral -> Neutral | $39.00 -> $43.00 | High | View details for Cantor Fitzgerald rating of DigitalOcean (NYSE:DOCN) on 2/26/2025 |
LCID Lucid Group | $2.51
-2.0% | 2/26/2025 | Reiterated by | Cantor Fitzgerald | Analyst Andres Sheppard | Neutral -> Neutral | $3.00 -> $3.00 | High | View details for Cantor Fitzgerald rating of Lucid Group (NASDAQ:LCID) on 2/26/2025 |
CART Maplebear | $39.89
+0.2% | 2/26/2025 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $55.00 -> $55.00 | High | View details for Cantor Fitzgerald rating of Maplebear (NASDAQ:CART) on 2/26/2025 |
SUPN Supernus Pharmaceuticals | $32.48
0.0% | 2/26/2025 | Reiterated by | Cantor Fitzgerald | Analyst K. Kluska | Neutral -> Neutral | $36.00 -> $36.00 | High | View details for Cantor Fitzgerald rating of Supernus Pharmaceuticals (NASDAQ:SUPN) on 2/26/2025 |
RARE Ultragenyx Pharmaceutical | $38.98
+2.4% | 2/26/2025 | Reiterated by | Cantor Fitzgerald | Analyst Kristen Kluska | Overweight -> Overweight | $118.00 -> $118.00 | Medium | View details for Cantor Fitzgerald rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 2/26/2025 |
SSTI SoundThinking | $15.52
-2.7% | 2/26/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $20.00 -> $20.00 | High | View details for Cantor Fitzgerald rating of SoundThinking (NASDAQ:SSTI) on 2/26/2025 |
SAIC Science Applications International | $121.03
-0.3% | 2/25/2025 | Upgraded by | Cantor Fitzgerald | Analyst C. Canfield | Hold | | Low | View details for Cantor Fitzgerald rating of Science Applications International (NYSE:SAIC) on 2/25/2025 |
PHAT Phathom Pharmaceuticals | $4.29
-1.6% | 2/25/2025 | Upgraded by | Cantor Fitzgerald | Analyst K. Kluska | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Phathom Pharmaceuticals (NASDAQ:PHAT) on 2/25/2025 |
LDOS Leidos | $147.19
-0.3% | 2/25/2025 | Upgraded by | Cantor Fitzgerald | Analyst C. Canfield | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Leidos (NYSE:LDOS) on 2/25/2025 |
DOMO Domo | $7.43
-1.8% | 2/25/2025 | Upgraded by | Cantor Fitzgerald | Analyst Y. Lee | Strong-Buy | | High | View details for Cantor Fitzgerald rating of Domo (NASDAQ:DOMO) on 2/25/2025 |
CACI CACI International | $457.70
+1.9% | 2/25/2025 | Upgraded by | Cantor Fitzgerald | Analyst C. Canfield | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of CACI International (NYSE:CACI) on 2/25/2025 |
BAH Booz Allen Hamilton | $119.98
+0.6% | 2/25/2025 | Upgraded by | Cantor Fitzgerald | Analyst C. Canfield | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of Booz Allen Hamilton (NYSE:BAH) on 2/25/2025 |
ASTS AST SpaceMobile | $23.21
-2.9% | 2/25/2025 | Upgraded by | Cantor Fitzgerald | Analyst C. Canfield | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of AST SpaceMobile (NASDAQ:ASTS) on 2/25/2025 |
AMTM Amentum | $21.76
-1.9% | 2/25/2025 | Upgraded by | Cantor Fitzgerald | Analyst C. Canfield | Hold | | Low | View details for Cantor Fitzgerald rating of Amentum (NYSE:AMTM) on 2/25/2025 |
MTSR Metsera | $24.11
+3.5% | 2/25/2025 | Initiated by | Cantor Fitzgerald | Analyst Prakhar Agrawal | Overweight | | High | View details for Cantor Fitzgerald rating of Metsera (NASDAQ:MTSR) on 2/25/2025 |
ASND Ascendis Pharma A/S | $170.44
+2.3% | 2/25/2025 | Target Raised by | Cantor Fitzgerald | Analyst Li Watsek | Overweight -> Overweight | $170.00 -> $200.00 | Low | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 2/25/2025 |
ZM Zoom Video Communications | $77.54
0.0% | 2/25/2025 | Reiterated by | Cantor Fitzgerald | Analyst T. Blakey | Neutral -> Neutral | $87.00 -> $87.00 | High | View details for Cantor Fitzgerald rating of Zoom Video Communications (NASDAQ:ZM) on 2/25/2025 |
RIOT Riot Platforms | $7.24
-2.4% | 2/25/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Brett Knoblauch | Overweight -> Overweight | $23.00 -> $21.00 | N/A | View details for Cantor Fitzgerald rating of Riot Platforms (NASDAQ:RIOT) on 2/25/2025 |
SIBN SI-BONE | $13.65
-4.4% | 2/25/2025 | Reiterated by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $25.00 -> $25.00 | High | View details for Cantor Fitzgerald rating of SI-BONE (NASDAQ:SIBN) on 2/25/2025 |
SOUN SoundHound AI | $9.29
-1.9% | 2/24/2025 | Upgraded by | Cantor Fitzgerald | Analyst T. Blakey | Hold | | Low | View details for Cantor Fitzgerald rating of SoundHound AI (NASDAQ:SOUN) on 2/24/2025 |
ORCL Oracle | $140.77
0.0% | 2/10/2025 | Downgraded by | Cantor Fitzgerald | Analyst T. Blakey | Overweight | | Medium | View details for Cantor Fitzgerald rating of Oracle (NYSE:ORCL) on 2/10/2025 |
MELI MercadoLibre | $2,330.85
+2.2% | 2/21/2025 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $2,150.00 -> $3,000.00 | High | View details for Cantor Fitzgerald rating of MercadoLibre (NASDAQ:MELI) on 2/21/2025 |
FIVN Five9 | $25.14
-0.8% | 2/21/2025 | Target Raised by | Cantor Fitzgerald | Analyst T. Blakey | Overweight -> Overweight | $46.00 -> $57.00 | High | View details for Cantor Fitzgerald rating of Five9 (NASDAQ:FIVN) on 2/21/2025 |
SABR Sabre | $2.37
-1.3% | 2/21/2025 | Reiterated by | Cantor Fitzgerald | Analyst B. Knoblauch | Neutral -> Neutral | $4.00 -> $4.00 | High | View details for Cantor Fitzgerald rating of Sabre (NASDAQ:SABR) on 2/21/2025 |
BKNG Booking | $5,099.28
+3.9% | 2/21/2025 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $4,900.00 -> $5,540.00 | High | View details for Cantor Fitzgerald rating of Booking (NASDAQ:BKNG) on 2/21/2025 |
BBIO BridgeBio Pharma | $38.36
+5.3% | 2/21/2025 | Reiterated by | Cantor Fitzgerald | Analyst Josh Schimmer | Overweight -> Overweight | $95.00 -> $95.00 | Low | View details for Cantor Fitzgerald rating of BridgeBio Pharma (NASDAQ:BBIO) on 2/21/2025 |
TVTX Travere Therapeutics | $20.81
+3.6% | 2/21/2025 | Reiterated by | Cantor Fitzgerald | Analyst P. Agrawal | Overweight -> Overweight | | Medium | View details for Cantor Fitzgerald rating of Travere Therapeutics (NASDAQ:TVTX) on 2/21/2025 |
CERS Cerus | $1.32
-2.9% | 2/21/2025 | Reiterated by | Cantor Fitzgerald | Analyst Ross Osborn | Overweight -> Overweight | $4.00 -> $4.00 | High | View details for Cantor Fitzgerald rating of Cerus (NASDAQ:CERS) on 2/21/2025 |
PRTA Prothena | $9.20
-5.1% | 2/21/2025 | Reiterated by | Cantor Fitzgerald | Analyst Eric Schmidt | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Prothena (NASDAQ:PRTA) on 2/21/2025 |
TRIP Tripadvisor | $12.45
-2.0% | 2/21/2025 | Target Lowered by | Cantor Fitzgerald | Analyst D. Mathivanan | Underweight -> Underweight | $14.00 -> $13.00 | High | View details for Cantor Fitzgerald rating of Tripadvisor (NASDAQ:TRIP) on 2/21/2025 |
NICE NICE | $155.86
-0.5% | 2/21/2025 | Target Lowered by | Cantor Fitzgerald | Analyst T. Blakey | Neutral -> Neutral | $176.00 -> $161.00 | Low | View details for Cantor Fitzgerald rating of NICE (NASDAQ:NICE) on 2/21/2025 |
M.A.G.A. is Finished – This Could be even Better (Ad) You’ve no doubt heard Trump’s rally cry: Make America Great Again.
But recently the President made a big change.
Make America Wealthy Again (M.A.W.A). When you see what could happen – I think you’ll be excited. |
RIVN Rivian Automotive | $13.66
+2.7% | 2/21/2025 | Downgraded by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Neutral | $13.00 -> $15.00 | Medium | View details for Cantor Fitzgerald rating of Rivian Automotive (NASDAQ:RIVN) on 2/21/2025 |
KRYS Krystal Biotech | $169.88
-0.4% | 2/20/2025 | Reiterated by | Cantor Fitzgerald | Analyst Josh Schimmer | Overweight -> Overweight | $215.00 | High | View details for Cantor Fitzgerald rating of Krystal Biotech (NASDAQ:KRYS) on 2/20/2025 |
WIX Wix.com | $169.59
-0.2% | 2/20/2025 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $260.00 -> $270.00 | High | View details for Cantor Fitzgerald rating of Wix.com (NASDAQ:WIX) on 2/20/2025 |
ETSY Etsy | $43.48
-5.7% | 2/20/2025 | Target Lowered by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $46.00 -> $43.00 | Medium | View details for Cantor Fitzgerald rating of Etsy (NASDAQ:ETSY) on 2/20/2025 |
ENVX Enovix | $6.70
-1.0% | 2/20/2025 | Reiterated by | Cantor Fitzgerald | Analyst Derek Soderberg | Overweight -> Overweight | $30.00 -> $30.00 | High | View details for Cantor Fitzgerald rating of Enovix (NASDAQ:ENVX) on 2/20/2025 |
KVYO Klaviyo | $30.49
+2.1% | 2/20/2025 | Target Raised by | Cantor Fitzgerald | Analyst Brett Knoblauch | Overweight -> Overweight | $47.00 -> $54.00 | High | View details for Cantor Fitzgerald rating of Klaviyo (NYSE:KVYO) on 2/20/2025 |
BMRN BioMarin Pharmaceutical | $63.69
+0.6% | 2/20/2025 | Reiterated by | Cantor Fitzgerald | Analyst Olivia Brayer | Overweight -> Overweight | $90.00 -> $90.00 | High | View details for Cantor Fitzgerald rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 2/20/2025 |
AXSM Axsome Therapeutics | $112.29
+2.2% | 2/19/2025 | Reiterated by | Cantor Fitzgerald | Analyst Charles Duncan | Overweight -> Overweight | $153.00 -> $153.00 | Low | View details for Cantor Fitzgerald rating of Axsome Therapeutics (NASDAQ:AXSM) on 2/19/2025 |
INSM Insmed | $72.00
+0.8% | 2/19/2025 | Reiterated by | Cantor Fitzgerald | Analyst Jennifer Kim | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Insmed (NASDAQ:INSM) on 2/19/2025 |
CRSP CRISPR Therapeutics | $38.67
+3.4% | 2/19/2025 | Reiterated by | Cantor Fitzgerald | Analyst Eric Schmidt | Neutral -> Neutral | | Medium | View details for Cantor Fitzgerald rating of CRISPR Therapeutics (NASDAQ:CRSP) on 2/19/2025 |
CNCK Coincheck Group | $7.01
-5.3% | 2/19/2025 | Initiated by | Cantor Fitzgerald | Analyst Brett Knoblauch | Overweight | $10.00 | Medium | View details for Cantor Fitzgerald rating of Coincheck Group (NASDAQ:CNCK) on 2/19/2025 |
SUPN Supernus Pharmaceuticals | $32.48
0.0% | 2/19/2025 | Downgraded by | Cantor Fitzgerald | Analyst K. Kluska | Overweight -> Neutral | $57.00 -> $36.00 | High | View details for Cantor Fitzgerald rating of Supernus Pharmaceuticals (NASDAQ:SUPN) on 2/19/2025 |
LRCX Lam Research | $71.67
+1.1% | 2/18/2025 | Reiterated by | Cantor Fitzgerald | Analyst C. Muse | Overweight -> Overweight | $100.00 -> $100.00 | High | View details for Cantor Fitzgerald rating of Lam Research (NASDAQ:LRCX) on 2/18/2025 |
WDC Western Digital | $43.86
+8.0% | 2/18/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $95.00 -> $95.00 | High | View details for Cantor Fitzgerald rating of Western Digital (NASDAQ:WDC) on 2/18/2025 |
INTC Intel | $20.10
-1.2% | 2/18/2025 | Target Raised by | Cantor Fitzgerald | Analyst Matthew Prisco | Neutral -> Neutral | $22.00 -> $29.00 | High | View details for Cantor Fitzgerald rating of Intel (NASDAQ:INTC) on 2/18/2025 |
PHAT Phathom Pharmaceuticals | $4.29
-1.6% | 2/14/2025 | Initiated by | Cantor Fitzgerald | Analyst K. Kluska | Overweight | $23.00 | High | View details for Cantor Fitzgerald rating of Phathom Pharmaceuticals (NASDAQ:PHAT) on 2/14/2025 |
MKSI MKS Instruments | $70.14
-1.8% | 2/13/2025 | Reiterated by | Cantor Fitzgerald | Analyst M. Prisco | Overweight -> Overweight | $140.00 -> $140.00 | High | View details for Cantor Fitzgerald rating of MKS Instruments (NASDAQ:MKSI) on 2/13/2025 |
KRNT Kornit Digital | $18.88
+1.4% | 2/13/2025 | Reiterated by | Cantor Fitzgerald | Analyst T. Jensen | Overweight -> Overweight | $39.00 -> $39.00 | Low | View details for Cantor Fitzgerald rating of Kornit Digital (NASDAQ:KRNT) on 2/13/2025 |
IREN Iris Energy | $6.11
-2.6% | 2/13/2025 | Reiterated by | Cantor Fitzgerald | Analyst Brett Knoblauch | Overweight -> Overweight | $23.00 -> $23.00 | High | View details for Cantor Fitzgerald rating of Iris Energy (NASDAQ:IREN) on 2/13/2025 |
THC Tenet Healthcare | $143.02
+3.4% | 2/13/2025 | Reiterated by | Cantor Fitzgerald | Analyst Sarah James | Overweight -> Overweight | $177.00 -> $177.00 | High | View details for Cantor Fitzgerald rating of Tenet Healthcare (NYSE:THC) on 2/13/2025 |
AUR Aurora Innovation | $7.24
-1.0% | 2/13/2025 | Reiterated by | Cantor Fitzgerald | Analyst A. Sheppard | Overweight -> Overweight | $10.00 -> $10.00 | High | View details for Cantor Fitzgerald rating of Aurora Innovation (NASDAQ:AUR) on 2/13/2025 |
TTD Trade Desk | $53.63
-1.9% | 2/13/2025 | Target Lowered by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $115.00 -> $100.00 | High | View details for Cantor Fitzgerald rating of Trade Desk (NASDAQ:TTD) on 2/13/2025 |
GHRS GH Research | $9.54
+6.0% | 2/13/2025 | Initiated by | Cantor Fitzgerald | Analyst Charles Duncan | Overweight | $14.00 | Low | View details for Cantor Fitzgerald rating of GH Research (NASDAQ:GHRS) on 2/13/2025 |
CVS CVS Health | $66.65
+2.5% | 2/12/2025 | Upgraded by | Cantor Fitzgerald | Analyst S. James | Neutral -> Overweight | | High | View details for Cantor Fitzgerald rating of CVS Health (NYSE:CVS) on 2/12/2025 |
HUM Humana | $262.41
+1.2% | 2/12/2025 | Reiterated by | Cantor Fitzgerald | Analyst Sarah James | Neutral -> Neutral | $290.00 -> $290.00 | Low | View details for Cantor Fitzgerald rating of Humana (NYSE:HUM) on 2/12/2025 |
DASH DoorDash | $192.89
+0.9% | 2/12/2025 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $200.00 -> $230.00 | Medium | View details for Cantor Fitzgerald rating of DoorDash (NASDAQ:DASH) on 2/12/2025 |
ZG Zillow Group | $65.98
-0.3% | 2/12/2025 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $62.00 -> $70.00 | Medium | View details for Cantor Fitzgerald rating of Zillow Group (NASDAQ:ZG) on 2/12/2025 |
LYFT Lyft | $12.40
-1.1% | 2/12/2025 | Target Lowered by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $15.00 -> $14.00 | High | View details for Cantor Fitzgerald rating of Lyft (NASDAQ:LYFT) on 2/12/2025 |
FRSH Freshworks | $14.77
+3.0% | 2/12/2025 | Target Raised by | Cantor Fitzgerald | Analyst Brett Knoblauch | Overweight -> Overweight | $18.00 -> $22.00 | High | View details for Cantor Fitzgerald rating of Freshworks (NASDAQ:FRSH) on 2/12/2025 |
FROG JFrog | $33.77
+1.5% | 2/12/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $38.00 -> $38.00 | High | View details for Cantor Fitzgerald rating of JFrog (NASDAQ:FROG) on 2/12/2025 |
PANW Palo Alto Networks | $186.93
+0.2% | 2/12/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Ruykhaver | Overweight -> Overweight | $223.00 -> $223.00 | N/A | View details for Cantor Fitzgerald rating of Palo Alto Networks (NASDAQ:PANW) on 2/12/2025 |
SHOP Shopify | $95.00
-4.0% | 2/12/2025 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $120.00 -> $120.00 | Low | View details for Cantor Fitzgerald rating of Shopify (NYSE:SHOP) on 2/12/2025 |
ASND Ascendis Pharma A/S | $170.44
+2.3% | 2/11/2025 | Reiterated by | Cantor Fitzgerald | Analyst Li Watsek | Overweight -> Overweight | $170.00 -> $170.00 | Low | View details for Cantor Fitzgerald rating of Ascendis Pharma A/S (NASDAQ:ASND) on 2/11/2025 |
MNDY monday.com | $280.99
+1.7% | 2/11/2025 | Target Raised by | Cantor Fitzgerald | Analyst T. Blakey | Overweight -> Overweight | $292.00 -> $380.00 | Low | View details for Cantor Fitzgerald rating of monday.com (NASDAQ:MNDY) on 2/11/2025 |
VRTX Vertex Pharmaceuticals | $509.50
+1.2% | 2/11/2025 | Reiterated by | Cantor Fitzgerald | Analyst Olivia Brayer | Overweight -> Overweight | $480.00 -> $480.00 | Medium | View details for Cantor Fitzgerald rating of Vertex Pharmaceuticals (NASDAQ:VRTX) on 2/11/2025 |
SEPN Septerna | $6.96
+0.4% | 2/11/2025 | Reiterated by | Cantor Fitzgerald | Analyst J. Schimmer | Overweight -> Overweight | $50.00 -> $50.00 | High | View details for Cantor Fitzgerald rating of Septerna (NASDAQ:SEPN) on 2/11/2025 |
DOMO Domo | $7.43
-1.8% | 2/11/2025 | Initiated by | Cantor Fitzgerald | Analyst Yi Fu Lee | Overweight | $11.00 | Medium | View details for Cantor Fitzgerald rating of Domo (NASDAQ:DOMO) on 2/11/2025 |
WDC Western Digital | $43.86
+8.0% | 2/10/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Overweight -> Overweight | $95.00 -> $95.00 | High | View details for Cantor Fitzgerald rating of Western Digital (NASDAQ:WDC) on 2/10/2025 |
PRLB Proto Labs | $35.11
-0.8% | 2/10/2025 | Target Raised by | Cantor Fitzgerald | Analyst Troy Jensen | Overweight -> Overweight | $40.00 -> $50.00 | Low | View details for Cantor Fitzgerald rating of Proto Labs (NYSE:PRLB) on 2/10/2025 |
SAIC Science Applications International | $121.03
-0.3% | 2/6/2025 | Upgraded by | Cantor Fitzgerald | Analyst C. Canfield | Hold | | Low | View details for Cantor Fitzgerald rating of Science Applications International (NYSE:SAIC) on 2/6/2025 |
LDOS Leidos | $147.19
-0.3% | 2/6/2025 | Upgraded by | Cantor Fitzgerald | Analyst C. Canfield | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Leidos (NYSE:LDOS) on 2/6/2025 |
CACI CACI International | $457.70
+1.9% | 2/6/2025 | Upgraded by | Cantor Fitzgerald | Analyst C. Canfield | Strong-Buy | | Medium | View details for Cantor Fitzgerald rating of CACI International (NYSE:CACI) on 2/6/2025 |
BAH Booz Allen Hamilton | $119.98
+0.6% | 2/6/2025 | Upgraded by | Cantor Fitzgerald | Analyst C. Canfield | Strong-Buy | | Low | View details for Cantor Fitzgerald rating of Booz Allen Hamilton (NYSE:BAH) on 2/6/2025 |
ARVN Arvinas | $9.62
+2.7% | 2/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst Li Watsek | Overweight -> Overweight | | High | View details for Cantor Fitzgerald rating of Arvinas (NASDAQ:ARVN) on 2/7/2025 |
PINS Pinterest | $25.31
-3.7% | 2/7/2025 | Target Raised by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $36.00 -> $48.00 | High | View details for Cantor Fitzgerald rating of Pinterest (NYSE:PINS) on 2/7/2025 |
AMZN Amazon.com | $184.42
-1.6% | 2/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $270.00 -> $270.00 | Low | View details for Cantor Fitzgerald rating of Amazon.com (NASDAQ:AMZN) on 2/7/2025 |
EXPE Expedia Group | $156.93
-2.0% | 2/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Neutral -> Neutral | $180.00 -> $210.00 | High | View details for Cantor Fitzgerald rating of Expedia Group (NASDAQ:EXPE) on 2/7/2025 |
NET Cloudflare | $120.87
-1.1% | 2/7/2025 | Target Raised by | Cantor Fitzgerald | Analyst T. Blakey | Neutral -> Neutral | $111.00 -> $149.00 | High | View details for Cantor Fitzgerald rating of Cloudflare (NYSE:NET) on 2/7/2025 |
ONTO Onto Innovation | $121.98
-0.2% | 2/7/2025 | Reiterated by | Cantor Fitzgerald | Analyst M. Prisco | Overweight -> Overweight | $250.00 -> $250.00 | Low | View details for Cantor Fitzgerald rating of Onto Innovation (NYSE:ONTO) on 2/7/2025 |
CACI CACI International | $457.70
+1.9% | 2/7/2025 | Initiated by | Cantor Fitzgerald | - | Overweight | $535.00 | Low | View details for Cantor Fitzgerald rating of CACI International (NYSE:CACI) on 2/7/2025 |
BAH Booz Allen Hamilton | $119.98
+0.6% | 2/7/2025 | Initiated by | Cantor Fitzgerald | - | Overweight | $160.00 | Low | View details for Cantor Fitzgerald rating of Booz Allen Hamilton (NYSE:BAH) on 2/7/2025 |
AMTM Amentum | $21.76
-1.9% | 2/7/2025 | Initiated by | Cantor Fitzgerald | Analyst C. Canfield | Strong-Buy -> Neutral | $25.00 | Medium | View details for Cantor Fitzgerald rating of Amentum (NYSE:AMTM) on 2/7/2025 |
SAIC Science Applications International | $121.03
-0.3% | 2/7/2025 | Initiated by | Cantor Fitzgerald | - | Neutral | $120.00 | Medium | View details for Cantor Fitzgerald rating of Science Applications International (NYSE:SAIC) on 2/7/2025 |
LDOS Leidos | $147.19
-0.3% | 2/7/2025 | Initiated by | Cantor Fitzgerald | - | Overweight | $185.00 | Medium | View details for Cantor Fitzgerald rating of Leidos (NYSE:LDOS) on 2/7/2025 |
MSTR Strategy | $380.11
-0.4% | 2/6/2025 | Target Raised by | Cantor Fitzgerald | Analyst B. Knoblauch | Overweight -> Overweight | $613.00 -> $619.00 | High | View details for Cantor Fitzgerald rating of Strategy (NASDAQ:MSTR) on 2/6/2025 |
PI Impinj | $92.13
+2.7% | 2/6/2025 | Target Lowered by | Cantor Fitzgerald | Analyst Troy Jensen | Overweight -> Overweight | $260.00 -> $133.00 | High | View details for Cantor Fitzgerald rating of Impinj (NASDAQ:PI) on 2/6/2025 |
DT Dynatrace | $46.95
-0.8% | 2/6/2025 | Reiterated by | Cantor Fitzgerald | Analyst T. Blakey | Neutral -> Neutral | $57.00 -> $57.00 | Low | View details for Cantor Fitzgerald rating of Dynatrace (NYSE:DT) on 2/6/2025 |
UBER Uber Technologies | $81.07
+2.1% | 2/6/2025 | Reiterated by | Cantor Fitzgerald | Analyst D. Mathivanan | Overweight -> Overweight | $80.00 -> $80.00 | High | View details for Cantor Fitzgerald rating of Uber Technologies (NYSE:UBER) on 2/6/2025 |
QCOM QUALCOMM | $148.46
+1.1% | 2/6/2025 | Reiterated by | Cantor Fitzgerald | Analyst Matthew Prisco | Neutral -> Neutral | $160.00 -> $160.00 | High | View details for Cantor Fitzgerald rating of QUALCOMM (NASDAQ:QCOM) on 2/6/2025 |
CSGS CSG Systems International | $60.13
-0.6% | 2/6/2025 | Target Raised by | Cantor Fitzgerald | Analyst Brett Knoblauch | Overweight -> Overweight | $64.00 -> $72.00 | High | View details for Cantor Fitzgerald rating of CSG Systems International (NASDAQ:CSGS) on 2/6/2025 |
